Sort by 'comments'
MSKCC Expert Dr. Ola Landgren on Can High Risk Disease Progress Cure Myeloma ?
Is high risk disease progress, the key to a cure for all myeloma patients? And what can researchers do to get new therapies to work for more than 30% of relapsed patients? Multiple myeloma has many different treatment options and…
Patient Advocates: Their Role and Benefits in Clinical Trial Groups
September is Prostate Cancer Awareness month and we are talking to patient advocates to get a better insight into their roles in major clinical groups. Mike Scott is talking to Tony Crispino, patient advocate to the Genitourinary Cancer Section of…
Role of Allogeneic Stem Cell Transplant in Myeloma Treatment with Dr. Krishna Komanduri
The role of allogeneic stem-cell transplantation is evolving in the paradigm of myeloma treatment. Despite its therapeutic potential of a myeloma cure, the use of donor stem cell transplantation is highly debated in the medical field due to the safety…
A Novel, More Precise, and Effective T-Cell Immunotherapy Approach for Myeloma
A lot of research is being done in immunotherapy for myeloma that is leading to new treatment options for patients. Dr. Ivan Borrello of John Hopkins is working on a completely, novel approach. This involves enhancing white blood cells to create a…
Will Modern Therapies Replace Auto and Allo Transplants in Myeloma Treatment?
In just the past 2 months, 3 new drugs for myeloma treatment have been approved by the FDA. In addition to this, there are many more drugs currently undergoing clinical trials. With so many more options for immunotherapy drugs coming…